The stocks of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has been Downgraded as a Hold from Buy by Stifel in its latest research note that was published on December 06. The stock also received a Buy rating from ROTH Capital with the price target of $20. This was contained in a research note published by the firm on February 08. The stock received a Buy rating and a price target of $18 to $17 in H.C. Wainwright’s research note that was published on November 02.
Conatus’s stock is covered by 3 analysts, with none of them rating the stock as Buy. It has been deemed to have strong buy by none of the analysts, 3 of them have rated it as a Hold while none of them rated it as sell. The situation was different a month ago when the stock was rated as a Buy by none of the analysts. None of them rated it as strong buy with 4 of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a sell. The above data shows that CNAT has an average analyst rating of Hold.
Conatus Pharmaceuticals Inc., which has current market capitalization of above $11 Million, published its last quarter earnings on September 30, 2019. The company was able to amass $3 Million in revenue, which saw a quarterly growth rate of -55.96 percent. During that quarter of the year, Conatus also recorded $-0.1 earnings per share (EPS) which is $0.02 above the $-0.12 estimated by the analysts, leading to a surprise factor of 16.67%.
CNAT surged by $0.00 during the normal trading session on Monday and reaching a high of $0.33 during the day while it closed the day at $0.33. The Conatus stock had a low trading volume of 0.35 million shares on that day, which is low compared to the average daily volume of 654.00M shares. CNAT has also lost 3.88% of its value over the past 7 days. However, the stock has surged by 3.26% in the 3 months of the year. Over the past six months meanwhile, it has lost 61.63% while it has lost 80.95% year-on date.
Shares in Hoegh LNG Partners LP (NYSE:HMLP) fell by -0.07 percent on Monday. The company’s stock began trading at $14.74 below the previous closing price of $14.75, and finished the day at $14.67. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -15.1% from its 3 months high price. However, taking another look at HMLP will indicate that it is trading +4.71% away from its 90-day low. Looking at the bigger picture, the Hoegh LNG Partners LP stock has dropped by -26.58% from its 52-week high while it has surged by +4.71% from its 52-week low price.
Let us now take a quick look at the stock’s short, medium and long-term indicators. Composite Indicator shows that HMLP stock was rated as a Sell by TrendSpotter. Its short-term indicators reveal that Hoegh has a 20-day average volume of 132825 shares. This has led to the HMLP price forecast being placed as a 100%Sell on an average basis. In the medium term, however, the HMLP stock has its 50-Day average volume of 98870 shares, with the indicators also rating it as a 100%Sell. Finally, in the long-term, the HMLP stocks have a 100-Day average volume of 105884 shares, with the long-term indicators rating the stock as just 100%Sell.
Hoegh has around 35 Million cash on their books at the moment. This figure will have to be compared and looked into, with their current liabilities standing at $64 Million. The Hoegh stock is bringing in revenue of over 12 months, which is roughly 145 Million. Despite all that, Hoegh LNG Partners LP is seeing things progressing very much as their y-o-y quarterly revenue surged by 65.95%.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 20.18%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 20.18%. Over the past 20 days, Hoegh’s Stochastic %K stood at 19.26% while its Stochastic %D was revealed to be 17.32%.